COMMUNIQUÉS West-GlobeNewswire

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
07/06/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – June 7, 2024 – 07:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, [...]
PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024
07/06/2024
Lyon (France) and Cambridge (MA, US), 7 June 2024 - 5.45pm CEST - PHAXIAM Therapeutics (Euronext: PHXM; FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial [...]
PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024
07/06/2024
Lyon (France) et Cambridge (MA, US), le 7 juin 2024 – 17h45 CEST – PHAXIAM Therapeutics (Euronext : PHXM ; FR0011471135) société biopharmaceutique qui développe des traitements innovants contre les infections [...]
Octane Medical acquires B. Braun’s global orthobiologics business
07/06/2024
“From the start, our corporate mission has been to make regenerative medicine the standard of care. We continue to be true to this goal, and it’s the key reason why we pursued this opportunity.” — Octane Medical Group [...]
Five-year data for Roche’s Evrysdi show the majority of treated children with a severe form of spinal muscular atrophy (SMA) achieved or maintained the ability to sit, stand or walk
07/06/2024
After five years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected to live past two years of age 96% of Evrysdi-treated children could swallow, 80% could feed [...]
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
07/06/2024
CARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and [...]
Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ
07/06/2024
KARL STORZ to acquire Asensus for $0.35 per share in cash Creating a leading surgical robotics division within KARL STORZ RESEARCH TRIANGLE PARK, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE [...]
Aeroflow Health Announces its Participation at America's Health Insurance Plans’ AHIP 2024 Flagship Conference in Las Vegas, Nevada
07/06/2024
Aeroflow’s Chief Medical Advisor to Lead a Discussion on Quality and Access to Care at the National Trade Association's Event in June ASHEVILLE, N.C., June 07, 2024 (GLOBE NEWSWIRE) -- Aeroflow Health , a pioneering [...]
European Bioplastics élit un nouveau Conseil d’administration avec Mariagiovanna Vetere et Franz Kraus comme coprésidents
07/06/2024
BRUXELLES, 07 juin 2024 (GLOBE NEWSWIRE) -- European Bioplastics (EUBP), l’association représentant les intérêts de l’industrie du bioplastique en Europe, a élu un nouveau Conseil d’administration lors de son Assemblée [...]
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
07/06/2024
Trading to commence effective on the market open June 14, 2024 WINTER SPRINGS, Fla., June 07, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (“Iradimed”) (NASDAQ: IRMD), a leading provider of innovative magnetic [...]
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
07/06/2024
DENVER, June 07, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]
STRATA Skin Sciences’ TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal
07/06/2024
Study published in the Journal of Clinical and Aesthetic Dermatology showed TheraClear®X Photopneumatic Acne therapy is a viable treatment option for patients with acne, especially for whom other acne treatments are [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07/06/2024
DALLAS, June 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic [...]
Nusano Names D. Scott Holbrook as Chairman of its Board
07/06/2024
VALENCIA, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced industry veteran D. Scott Holbrook as chairman of its board. [...]
GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend
07/06/2024
Extended 10-year Agreement to Upgrade Gamma Knife® Perfexion™ with Elekta Esprit SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American [...]
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
07/06/2024
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced [...]
Epic Bio to Present IND-Enabling Data Package for EPI-321 at FSHD International Research Congress
07/06/2024
SOUTH SAN FRANCISCO, Calif., June 07, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced its participation in the [...]
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
07/06/2024
Fireside chat scheduled for Tuesday, June 11, 2024, at 1:20 PM ET NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/06/2024
SAN DIEGO, June 07, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of [...]

Pages